🔎 Trials Near Me

Domov › Debelost › Minnesota

Klinične študije za Debelost v Minnesota

29 študij za Debelost išče udeležence na lokacijah v Minnesota.

Mesta v Minnesota

Uradno besedilo študije (angleško)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • International Diabetes Center, Minneapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07533175

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • International Diabetes Center, Minneapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07564414

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • University of Minnesota, Minneapolis
  • Synexus Clinical Research US-MN, Richfield
Vključevanje udeležencevFaza 3
Starost 8–18 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07253285

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

  • Headlands Research - Twin Cities, Maplewood
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07823608

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • University of Minnesota Masonic Children's Hospital, Minneapolis
  • Mayo Clinic - PIN, Rochester
  • Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Headlands Research-Twin Cities, Maplewood
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
  • Minneapolis Heart Institute Foundation, Minneapolis
Vključevanje udeležencevFaza 3
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Mankato
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Mankato Clinic, Mankato
  • Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
  • University of Minnesota, Minneapolis
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • International Diabetes Center At Park Nicollet, Minneapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Dilworth
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 25–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07815678

Exercise Response in Humans With Obesity

  • Mayo Clinic in Rochester, Rochester
Vključevanje udeležencevOpazovalna študija
Starost 20–45 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05857150

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Mankato
  • ACCOMPLISH-2 Research Site, Minneapolis
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Vključevanje udeležencev
Starost 18–80 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT05225233

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Children's Hospitals and Clinics of Minnesota, Minneapolis
Vključevanje udeležencevFaza 2
Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Mankato
  • ACCOMPLISH-1 Research Site, Richfield
Vključevanje udeležencevFaza 3
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity

  • Mayo Clinic in Rochester, Rochester
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–55 · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07031297

Fibrosis Lessens After Metabolic Surgery

  • Mayo Clinic, Rochester
Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci
Starost 18–75 · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06374875

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

  • Clinical Research Institute of Minnesota, Minneapolis
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07728383

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

  • Minneapolis VA Health Care System, Minneapolis
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06390345

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

  • Mayo Clinic, Rochester
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 11. jun. 2026 · NCT06770049

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

  • Mayo Clinic in Rochester, Rochester
Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 22. maj 2026 · NCT06416969

Circadian Rhythms in Human Adipose

  • Mayo Clinic, Rochester
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–55 · Vsi spoli · Posodobljeno 14. apr. 2026 · NCT06891534

Regional Lipolysis Insulin Regulation

  • Mayo Clinic in Rochester, Rochester
Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT06392854

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

  • Mayo Clinic, Rochester
Vključevanje udeležencevFaza 4Omenja plačilo za udeležence
Starost 18–65 · Vsi spoli · Posodobljeno 11. mar. 2026 · NCT07213466

Insulin Regulation of Lipolysis and Lipolysis Proteins

  • Mayo Clinic in Rochester, Rochester
Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci
Starost 18–55 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT03866408

Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

  • University of Minnesota, Minneapolis
Vključevanje udeležencevFaza 1/2
Starost 21–75 · Vsi spoli · Posodobljeno 17. dec. 2025 · NCT06226077

Weight Loss Through Mayo Clinic Diet

  • Mayo Clinic in Rochester, Rochester
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–64 · Vsi spoli · Posodobljeno 7. okt. 2025 · NCT06862375

Tirzepatide in PWS, HO and GNSO

  • Children's Minnesota, Saint Paul
Vključevanje udeležencevFaza 4
Starost 18–26 · Vsi spoli · Posodobljeno 16. sep. 2025 · NCT06901245

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.